David Osoba
QOL Consulting
Vancouver
British Columbia
Canada
Name/email consistency: high
- Translating the science of patient-reported outcomes assessment into clinical practice. Osoba, D. J. Natl. Cancer Inst. Monographs (2007)
- Evaluating health-related quality of life in cancer clinical trials: the National Cancer Institute of Canada Clinical Trials Group experience. Osoba, D., Bezjak, A., Brundage, M., Pater, J. Value. Health (2007)
- Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment. Osoba, D., Hsu, M.A., Copley-Merriman, C., Coombs, J., Johnson, F.R., Hauber, B., Manjunath, R., Pyles, A. Qual. Life. Res (2006)
- Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group. Osoba, D., Bezjak, A., Brundage, M., Zee, B., Tu, D., Pater, J. Eur. J. Cancer (2005)
- A taxonomy of the uses of health-related quality-of-life instruments in cancer care and the clinical meaningfulness of the results. Osoba, D. Med. Care (2002)
- Effects on quality of life of combined trastuzumab and chemotherapy in women with metastatic breast cancer. Osoba, D., Slamon, D.J., Burchmore, M., Murphy, M. J. Clin. Oncol. (2002)
- Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma: a randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine. Osoba, D., Northfelt, D.W., Budd, D.W., Himmelberger, D. Cancer Invest. (2001)
- Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide. Osoba, D., Brada, M., Yung, W.K., Prados, M.D. Eur. J. Cancer (2000)